@FiercePharma: India's Dr. Reddy's responds to U.S. FDA warning letter. FiercePharmaAsia article | Follow @FiercePharma
@CarlyHFierce: I'm sorry, but you had 20 years to brainstorm on this, and you came up with "Dengvaxia?" $SNY | Follow @CarlyHFierce
> Biogen ($BIIB) may be backing off plans to expand in the Boston area after announcing plans to cut 11% of its workforce. Story
> Biotech Alnylam Pharmaceuticals ($ALNY) threw down a gauntlet to Alexion ($ALXN), laying out plans to bring to market a drug that would challenge Alexion's orphan drug Soliris, sometimes called the worlds' most expensive drug. Story
> EMA Executive Director Guido Rasi laid out a 5-year plan for drug oversight in Europe which includes faster drug approvals, accomplished without compromising quality. Story
> Indiana-based Eli Lilly ($LLY) has made a $30,000 grant to help fund 100 drug disposal sites at pharmacies in the state. More
Medical Device News
@FierceMedDev: ICYMI yesterday: Chemotherapy cooling cap to reduce hair loss for breast cancer patients gets FDA nod. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Edwards grabs option to acquire transcather mitral valve replacement startup. Article | Follow @VarunSaxena2
@EmilyWFierce: Cornell scientists create first litter of puppies through in vitro fertilization. FierceAnimalHealth story | Follow @EmilyWFierce
> Edwards bets on treating degenerative regurgitation via mitral repair with Harpoon investment. More
> Bloomberg: Embattled Theranos CEO continues to beat the 'transparency' drum. Story
> MicroTransponder reels in $5.5M for stroke neurostimulation device. Article
Biotech News
@FierceBiotech: With Roche in the rearview mirror, Constellation Pharma grabs $55M round. Article | Follow @FierceBiotech
@JohnCFierce: Now we get to see if Merck KGaA can swing big and actually hit the ball. Article | Follow @JohnCFierce
> After failing a PhII/III, Raptor steers Huntington's drug into a pivotal trial. Article
> Puma's once-vaunted cancer drug dogged by side effects in Phase II results. Item
> In a win for NYC, gut-brain biotech Kallyope launches with $44M. News
> FierceBiotech Radio on the burning hole in Gilead's $25B pocket and AbbVie's future in hematology. More | Subscribe
CRO News
> Icon buys a trial site network with an eye on patient data. News
> WuXi and PRA break up their Chinese joint venture. More
> Charles River digs into Parkinson's R&D with Fox Foundation in tow. Story
> Quintiles extends its R&D hand-holding service to biopharmas large and small. Report
> Restructured AMRI cuts the ribbon on a drug discovery hub. Article
Pharma Manufacturing News
> Sucampo finalizes $278M deal of R-Tech Ueno's manufacturing plant in Japan. News
> Axxess Pharma has tapped SDC Nutrition for product manufacturing. Report
> FDA issues import alert on Pan Pharma, ramping up its pressure on the India drugmaker. Story
> Eli Lilly to manufacture human and animal drugs in separate facilities. Article
> Study: Shortfall of skilled inspectors in India hinders pharma industry. Item
Pharma Asia News
> WuXi and PRA Health amend ties in China. Item
> U.S. FDA files import alert on India's Pan Drugs. More
> China aims precision medicine plans at chronic diseases. Report
> Bangladesh again noted for dominant domestic drug manufacture. Story
> Takeda inks pact with Cour for celiac disease therapy via nanoparticles. Article